FDA.reportPublic FDA data

sodium zirconium cyclosilicate 5 GM Powder for Oral Suspension

RxCUI
2047633
RxNorm name
sodium zirconium cyclosilicate 5 GM Powder for Oral Suspension
Display name
sodium zirconium cyclosilicate 5 GM Powder for Oral Suspension
Full name
sodium zirconium cyclosilicate 5 GM Powder for Oral Suspension
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:08

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
LOKELMASODIUM ZIRCONIUM CYCLOSILICATEAstraZeneca Pharmaceuticals LP90bf8e28-748d-4e4b-a19f-9cf483370eff2024-02-08Warnings, Adverse reactionsExact identifier
rxcui: 2047633
LOKELMASODIUM ZIRCONIUM CYCLOSILICATEA-S Medication Solutions7f7ed64d-8480-4143-a207-29c24a0b93632023-05-31Warnings, Adverse reactionsExact identifier
rxcui: 2047633

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
90bf8e28-748d-4e4b-a19f-9cf483370effsodium zirconium cyclosilicate 5 GM Powder for Oral SuspensionPSN28These highlights do not include all the information needed to use LOKELMA ® safely and effectively. See full prescribing information for LOKELMA ® . LOKELMA ® (sodium zirconium cyclosilicate) for oral suspension Initial U.S. Approval: 201820240208
90bf8e28-748d-4e4b-a19f-9cf483370effsodium zirconium cyclosilicate 5000 MG Powder for Oral SuspensionSCD28These highlights do not include all the information needed to use LOKELMA ® safely and effectively. See full prescribing information for LOKELMA ® . LOKELMA ® (sodium zirconium cyclosilicate) for oral suspension Initial U.S. Approval: 201820240208
90bf8e28-748d-4e4b-a19f-9cf483370effsodium zirconium cyclosilicate 5 GM Powder for Oral SuspensionSY28These highlights do not include all the information needed to use LOKELMA ® safely and effectively. See full prescribing information for LOKELMA ® . LOKELMA ® (sodium zirconium cyclosilicate) for oral suspension Initial U.S. Approval: 201820240208
7f7ed64d-8480-4143-a207-29c24a0b9363sodium zirconium cyclosilicate 5 GM Powder for Oral SuspensionSY1These highlights do not include all the information needed to use LOKELMA ® safely and effectively. See full prescribing information for LOKELMA ® . LOKELMA ® (sodium zirconium cyclosilicate) for oral suspension Initial U.S. Approval: 201820230531
7f7ed64d-8480-4143-a207-29c24a0b9363sodium zirconium cyclosilicate 5 GM Powder for Oral SuspensionPSN1These highlights do not include all the information needed to use LOKELMA ® safely and effectively. See full prescribing information for LOKELMA ® . LOKELMA ® (sodium zirconium cyclosilicate) for oral suspension Initial U.S. Approval: 201820230531
7f7ed64d-8480-4143-a207-29c24a0b9363sodium zirconium cyclosilicate 5000 MG Powder for Oral SuspensionSCD1These highlights do not include all the information needed to use LOKELMA ® safely and effectively. See full prescribing information for LOKELMA ® . LOKELMA ® (sodium zirconium cyclosilicate) for oral suspension Initial U.S. Approval: 201820230531